Injectable biocompatible nanocomposites of Prussian blue nanoparticles and bacterial cellulose as a safe and effective photothermal cancer therapy

Table 1 Viability of cells treated with various forms of PB NPs

Particle name	Method	Cell viability at a certain concentration	Ref.
PB@Bg-C₃N₄	In situ reduction	95.6% at 200 μg mL⁻¹	[27]
NaDyF₄:50%Lu@PB	Solvothermal method	86% at 1000 μg mL⁻¹	[29]
HCPT@HPBNs@PAA/PAH/HA-g-PEG	Self-etching reaction and PEGylation by ECD-NHS reaction	56% at 30 μg mL⁻¹	[61]
PEGylated PB NPs	Precipitation, thin film hydration method	84.2% at 40 μg mL⁻¹	[62]
IBC-PB composites	Trituration and self-etching reaction	83.59% at 2500 μg mL⁻¹	Our study

PB@ Bg-C₃N₄ a boracic-acid-modified graphite carbon nitride and Prussian blue nanohybrid, HCPT@HPBNs@PAA/PAH/HA-g-PEG 10-hydroxycamptothecin loaded hyaluronic acid grafting polyethylene glycol modified hollow Prussian blue nanoparticles, NaDyF₄:50%Lu@PB Prussian blue-coated NaDyF₄ doped with Lu³⁺ ions nanocomposites, PEGylated PB NPs polyethylene glycol-attached Prussian blue nanoparticles

ISSN: 1477-3155